Genomic News and Research

RSS

Synthetic hydrogel-based lymphoma tumor model paves way for personalized cancer therapies

In recent years, innovative cancer drugs that target specific molecular drivers of the disease have been embraced as the treatment of choice for many types of cancer.

29 Mar 2023

VR imaging system illuminates functional brain network dynamics in autism model

An international research collaboration has developed a VR imaging system that can measure a wide range of neural activity in the cortices of mice during active behavior.

28 Mar 2023

Using a long-read approach to gain better understanding of DNA mutations in cancer genomes

Looking to learn more from genomics sequencing about DNA mutations and cancer, researchers applied a long-read approach to get a broader genomic view.

27 Mar 2023

Beethoven's cause of death revealed through DNA analysis of his hair

In a recent article published in the journal Current Biology, an international team of researchers sequenced the whole genome to high coverage from eight authenticated hair strands from Ludwig van Beethoven, one of the most influential European classical music composers born in 1770. He died on March 27, 1827.

27 Mar 2023

Epigenome reprogramming after SARS-CoV-2 infection

Researchers performed a 3D evaluation of SARS-CoV-2 infected human cells.

27 Mar 2023

Breast tumors of women from different racial groups have diverse cellular, microbial and genomic features

The breast tumors of Asian, Black and white women have very different cellular, microbial and genomic features that could potentially be used to personalize care or predict disease progression, according to new research by investigators at the Johns Hopkins Kimmel Cancer Center.

27 Mar 2023

New statement suggests next steps to interpret incidentally identified gene variants related to heart disease

Increasing use of genetic testing means people may discover they have a gene variant associated with some types of cardiovascular disease (CVD).

27 Mar 2023

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

In this interview, NewsMedical speaks with Dr. Yuying Wang, R&D Director (Oncology), from BGI Genomics, about colorectal cancer and the development and application of COLOTECT® 1.0, a non-invasive fecal DNA test for the detection of colorectal cancer and pre-cancerous lesions.

From BGI Genomics 27 Mar 2023

Advancements in understanding and treating breast cancer

Researchers describe recent advancements in breast cancer research.

26 Mar 2023

High-resolution mass spectrometric rapid identification of Candida auris

A recent study published in the Journal of Fungi used a novel OrbitrapTM high-resolution mass spectrometric technology coupled with liquid chromatography to identify geographically different clades of Candida auris (C. auris) isolates. This proof-of-concept methodology could accurately detect C. auris in the microbiology laboratory.

23 Mar 2023

Candida auris infection without epidemiologic links to a prior outbreak

The Centers for Disease Control and Prevention (CDC) has classified Candida auris (C. auris) as an urgent public threat due to its role in elevating mortality, its ability to persist in hospital environments, and the high possibility of developing pan-drug resistance.

23 Mar 2023

Reinfections with Omicron VOCs occur more frequently and over shorter intervals

In a recent study published in Nature's Communications Biology journal, researchers in the United States of America (USA) employed next-generation sequencing (NGS) data to assess the rise in reinfections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

23 Mar 2023

Pet dogs across the USA are becoming increasingly resistant to benzimidazole treatment

In a recent study published in the journal PLOS Pathogens, researchers in the United States of America (USA) and Canada found molecular evidence that the parasitic hookworms (Ancylostoma caninum) in pet dogs across the USA are becoming increasingly resistant to benzimidazole, a broad-spectrum anthelmintic drug used for infection control.

22 Mar 2023

Zoonotic agent Erysipelothrix rhusiopathiae caused mass mortality of harbor porpoises

In a recent article published in the Emerging Infectious Diseases Journal, researchers in the Netherlands described a mortality event that killed hundreds of harbor porpoises (Phocoena phocoena), a small cetacean, along the Netherlands coastline, in August 2021.

22 Mar 2023

Higher plasma caffeine concentrations might reduce body fat and type 2 diabetes risk

In a recent study published in the journal BMJ Medicine, researchers in the United Kingdom and Sweden investigated the probable causality of long-term serum caffeine concentrations on type 2 diabetes (T2D), adiposity, and major cardiovascular diseases (CVDs).

22 Mar 2023

Emergence and persistency of SARS-CoV-2 Omicron BA.2.3.7 in Taiwan

Researchers utilize whole-genome surveillance to monitor community transmission and evolution of SARS-CoV-2 in Taiwan.

22 Mar 2023

Common genetic signature may increase a person's risk of developing substance use disorders

A new study suggests that a common genetic signature may increase a person's risk of developing substance use disorders, regardless of whether the addiction is to alcohol, tobacco, cannabis or opioids.

22 Mar 2023

Study finds shared genetic risk variants across different substance use disorders

By combing through genomic data of over 1 million people, scientists have identified genes commonly inherited across addiction disorders, regardless of the substance being used.

22 Mar 2023

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced that its first product based on its novel Illumina Complete Long Read technology is now available to order.

From Illumina, Inc. 22 Mar 2023

Researchers identify the cellular glitches underlying a rare genetic disorder

The cellular glitches underlying a rare genetic disorder called activated PI3K Delta syndrome 2 (APDS2) have been identified by researchers at the Garvan Institute of Medical Research. The disorder is caused by genetic variations that disrupt immune cell signaling through a protein called PI3K.

21 Mar 2023

Genomic News and Research

Synthetic hydrogel-based lymphoma tumor model paves way for personalized cancer therapies

VR imaging system illuminates functional brain network dynamics in autism model

Using a long-read approach to gain better understanding of DNA mutations in cancer genomes

Beethoven's cause of death revealed through DNA analysis of his hair

Epigenome reprogramming after SARS-CoV-2 infection

Breast tumors of women from different racial groups have diverse cellular, microbial and genomic features

New statement suggests next steps to interpret incidentally identified gene variants related to heart disease

Ask the Expert: 7 Questions about Colorectal Cancer & Non-invasive Fecal DNA Testing

Advancements in understanding and treating breast cancer

High-resolution mass spectrometric rapid identification of Candida auris

Candida auris infection without epidemiologic links to a prior outbreak

Reinfections with Omicron VOCs occur more frequently and over shorter intervals

Pet dogs across the USA are becoming increasingly resistant to benzimidazole treatment

Zoonotic agent Erysipelothrix rhusiopathiae caused mass mortality of harbor porpoises

Higher plasma caffeine concentrations might reduce body fat and type 2 diabetes risk

Emergence and persistency of SARS-CoV-2 Omicron BA.2.3.7 in Taiwan

Common genetic signature may increase a person's risk of developing substance use disorders

Study finds shared genetic risk variants across different substance use disorders

Illumina launches its first product enabling long- and short-read sequencing on one instrument

Researchers identify the cellular glitches underlying a rare genetic disorder

The art of CRISPR: The power and promise of gene editing eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News